BIOMED AI

Biomed AI, Inc. is a technology company built to transform the drug discovery and development process using Human Real World Evidence and artificial intelligence-driven computation... The Biomed team has successfully demonstrated the application of AI in developing new drug therapeutics for the treatment of neurodegenerative diseases. We plan to deploy our AI technology to optimize the Phase 2 and Phase 3 clinical trials of our drug NA-831 for the treatment and prevention of Alzheimer's disease.

Also known as: Biomed AI, Inc.

Primary location: San Jose United States